Heranba Industries Ltd
Incorporated in 1994, Heranba Industries Ltd is engaged in the manufacturing of a diverse range of agrochemicals such as insecticides, herbicides, fungicides and public health products for pest control. [1]
- Market Cap ₹ 1,223 Cr.
- Current Price ₹ 306
- High / Low ₹ 562 / 205
- Stock P/E 29.4
- Book Value ₹ 231
- Dividend Yield 0.33 %
- ROCE 9.10 %
- ROE 5.93 %
- Face Value ₹ 10.0
Pros
- Company is expected to give good quarter
- Company's working capital requirements have reduced from 69.3 days to 25.9 days
Cons
- The company has delivered a poor sales growth of 9.47% over past five years.
- Company has a low return on equity of 9.13% over last 3 years.
- Earnings include an other income of Rs.60.9 Cr.
- Dividend payout has been low at 6.50% of profits over last 3 years
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals
Part of BSE SmallCap BSE Allcap BSE Commodities
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 514 | 582 | 741 | 1,004 | 951 | 1,219 | 1,450 | 1,324 | 1,275 | 1,496 | 1,681 | |
| 470 | 534 | 653 | 873 | 822 | 997 | 1,190 | 1,163 | 1,178 | 1,413 | 1,626 | |
| Operating Profit | 44 | 48 | 88 | 131 | 129 | 221 | 260 | 161 | 97 | 83 | 55 |
| OPM % | 9% | 8% | 12% | 13% | 14% | 18% | 18% | 12% | 8% | 6% | 3% |
| 1 | 2 | 5 | 7 | 17 | 7 | 19 | 14 | 30 | 46 | 61 | |
| Interest | 13 | 12 | 12 | 11 | 9 | 5 | 4 | 8 | 12 | 26 | 31 |
| Depreciation | 4 | 4 | 5 | 6 | 8 | 15 | 20 | 23 | 25 | 28 | 28 |
| Profit before tax | 28 | 35 | 76 | 122 | 129 | 208 | 255 | 144 | 90 | 74 | 57 |
| Tax % | 39% | 41% | 39% | 38% | 24% | 26% | 26% | 24% | 27% | 27% | |
| 17 | 20 | 47 | 75 | 98 | 154 | 189 | 110 | 66 | 54 | 42 | |
| EPS in Rs | 21.61 | 26.01 | 60.02 | 19.31 | 25.00 | 38.54 | 47.25 | 27.52 | 16.58 | 13.50 | 10.39 |
| Dividend Payout % | 13% | 10% | 9% | 5% | 6% | 4% | 4% | 5% | 8% | 7% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 9% |
| 3 Years: | 1% |
| TTM: | 30% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -11% |
| 3 Years: | -34% |
| TTM: | -58% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -16% |
| 1 Year: | -31% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 16% |
| 3 Years: | 9% |
| Last Year: | 6% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8 | 8 | 8 | 39 | 39 | 40 | 40 | 40 | 40 | 40 |
| Reserves | 91 | 108 | 150 | 189 | 282 | 488 | 674 | 776 | 837 | 886 |
| 96 | 84 | 76 | 50 | 43 | 52 | 91 | 93 | 144 | 243 | |
| 130 | 120 | 217 | 282 | 261 | 263 | 302 | 250 | 378 | 527 | |
| Total Liabilities | 325 | 321 | 450 | 560 | 625 | 843 | 1,108 | 1,159 | 1,399 | 1,696 |
| 37 | 38 | 46 | 51 | 95 | 133 | 193 | 186 | 240 | 240 | |
| CWIP | 0 | 0 | 1 | 16 | 38 | 10 | 14 | 42 | 11 | 4 |
| Investments | 0 | 0 | 0 | 0 | 4 | 10 | 2 | 1 | 2 | 3 |
| 287 | 282 | 403 | 493 | 488 | 690 | 898 | 930 | 1,146 | 1,449 | |
| Total Assets | 325 | 321 | 450 | 560 | 625 | 843 | 1,108 | 1,159 | 1,399 | 1,696 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 52 | 54 | 60 | 98 | 122 | 136 | 137 | ||||
| -25 | -52 | -41 | -82 | -100 | -264 | -182 | ||||
| -26 | -20 | 62 | -6 | -18 | 41 | 72 | ||||
| Net Cash Flow | 1 | -18 | 82 | 10 | 4 | -87 | 27 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 102 | 78 | 100 | 92 | 99 | 102 | 112 | 107 | 143 | 137 |
| Inventory Days | 76 | 86 | 68 | 60 | 83 | 78 | 100 | 122 | 100 | 81 |
| Days Payable | 96 | 84 | 129 | 123 | 122 | 92 | 96 | 77 | 117 | 142 |
| Cash Conversion Cycle | 83 | 79 | 39 | 29 | 61 | 89 | 116 | 152 | 125 | 76 |
| Working Capital Days | 30 | 36 | 39 | 39 | 66 | 81 | 94 | 106 | 76 | 26 |
| ROCE % | 24% | 41% | 52% | 43% | 45% | 37% | 18% | 11% | 9% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Change in Management
16 Oct - K D Practice's internal auditor Kamal Dharewa resigned effective October 15, 2025; no concerns; new appointment pending.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
10 Oct - Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the Quarter ended 30th September, 2025.
-
Announcement under Regulation 30 (LODR)-Change in Management
7 Oct - Aniel Gidwani resigned as Asst. VP—Procurement; ceased as senior management effective Oct 7, 2025.
- Closure of Trading Window 27 Sep
-
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
26 Sep - 33rd AGM Sep 24, 2025: all nine resolutions passed; dividend confirmed; director appointments; approvals for loans, guarantees, related-party transactions.
Annual reports
Concalls
-
Feb 2025TranscriptPPTREC
-
Nov 2024Transcript PPT
-
Aug 2024TranscriptNotesPPT
-
May 2024TranscriptNotesPPT
-
Feb 2024TranscriptNotesPPT
-
Nov 2023TranscriptNotesPPT
-
Nov 2023TranscriptNotesPPT
-
Aug 2023TranscriptNotesPPT
-
May 2023TranscriptNotesPPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Jan 2022TranscriptNotesPPT
-
Dec 2021TranscriptPPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
Aug 2021TranscriptNotesPPT
-
Jun 2021Transcript PPT
Product Portfolio
The company is India’s leading agrochemical player, manufacturing Synthetic Pyrethroids and their intermediates. Its product portfolio includes: [1]